Inventor
Teddy Halmos
Inventor
Laval, CA
Overview
Patents· 29 as inventor
Public. Assignee & technology derived from the patent record. Each patent links to its LexDana page.
A61Pprimary
A61PSpecific therapeutic activity of chemical compounds or medicinal preparations24%
C07DHeterocyclic compounds22%
A61KPreparations for medical, dental or toiletry purposes21%
C07KPeptides18%
C12PFermentation or enzyme-using processes to synthesise a desired chemical compound or composition or to separate optical isomers from a racemic mixture9%
Y02ATechnologies for adaptation to climate change3%
C07CAcyclic or carbocyclic compounds3%
C12NMicroorganisms or enzymes1%
PatentTitleYear
9,708,332'Respiratory syncytial virus inhibitors'20178,710,230'Inhibitors of human immunodeficiency virus replication'20148,377,960'Inhibitors of human immunodeficiency virus replication'20138,354,429'Inhibitors of human immunodeficiency virus replication'20138,349,839'Inhibitors of HIV replication'20138,067,438'Hepatitis C inhibitor compounds'20117,939,667'Hepatitis C inhibitor compounds'2011RE042164'Hepatitis C inhibitor tri-peptides'2011RE041894'Hepatitis C inhibitor tri-peptides'20107,767,818'Hepatitis C inhibitor dipeptide analogs'20107,749,961'Macrocyclic peptides active against the hepatitis C virus'2010RE041356'Hepatitis C inhibitor tri-peptides'20107,705,146'Hepatitis C inhibitor peptide analogs'20107,696,242'Hepatitis C inhibitor peptide analogs'20107,642,235'Macrocyclic peptides active against the hepatitis C virus'20107,585,845'Hepatitis C inhibitor compounds'20097,511,157'Hepatitis C inhibitor dipeptide analogs'2009RE040525'Hepatitis C inhibitor tri-peptides'20086,608,027'Macrocyclic peptides active against the hepatitis C virus'20036,534,523'Hepatitis C inhibitor tri-peptides'20036,420,380'Hepatitis C inhibitor tri-peptides'20026,410,531'Hepatitis C inhibitor tri-peptides'20026,329,379'Hepatitis C inhibitor tri-peptides'20016,329,417'Hepatitis C inhibitor tri-pepitides'20016,323,180'Hepatitis C inhibitor tri-peptides'20016,143,715'Hepatitis C inhibitor peptide analogues'20005,565,476'N-(hydroxyethyl)butanediamide derivatives'19965,554,634'N-(hydroxyethyl)butanediamide derivatives'19965,523,315'N-(hydroxyethyl)butanediamide derivatives'1996Career & activity timeline
Assembled from patent assignee/location history and declaration credentials.
1996Patents assigned to BIO MEGA BOEHRINGER INGELHEIM (3)· patent assignee history
1996Based in St. Laurent, CA· patent location history
2000–2011Patents assigned to BOEHRINGER INGELHEIM CA LTD (12)· patent assignee history
2000–2014Based in Laval, CA· patent location history
2009–2013Patents assigned to BOEHRINGER INGELHEIM INT (10)· patent assignee history
2011–2013Patents assigned to HALMOS TEDDY (4)· patent assignee history
2013–2014Patents assigned to GILEAD SCIENCES INC (3)· patent assignee history
2017Based in Burlington, CA· patent location history
Inventor activity
Assignee and location history derived from the patent record.
Assignees
| Assignee | Patents | Span |
|---|---|---|
| BOEHRINGER INGELHEIM CA LTD | 12 | 2000–2011 |
| BOEHRINGER INGELHEIM INT | 10 | 2009–2013 |
| HALMOS TEDDYself | 4 | 2011–2013 |
| BIO MEGA BOEHRINGER INGELHEIM | 3 | 1996 |
| GILEAD SCIENCES INC | 3 | 2013–2014 |
Locations
| Location | Patents | Span |
|---|---|---|
| Laval, CA | 25 | 2000–2014 |
| St. Laurent, CA | 3 | 1996 |
| Burlington, CA | 1 | 2017 |